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Abstract
PURPOSE: To evaluate the effects of ovariectomy and the hyperprolactinemia procedure in the tibial epiphyseal growth 
plate of female mice. METHODS: In this study, the epiphyseal growth plate of ovariectomized (OVX) and/or rendered 
hyperprolactinemic female mice by 50 days of treatment with 200 μg metoclopramide (M) was evaluated morphologically, 
morphometrically and immuno-histochemically. Forty female and adult mice were divided into four groups according to treatment: 
V group — animals treated with saline solution; H group — hyperprolactinemic animals; Ovx/V group — ovariectomized 
animals and treated with saline solution; Ovx/H group — hyperprolactinemic and ovariectomized animals. After the treatment 
period, the animals were sacrificed, tibia was removed and fixed in 10% buffered formalin and decalcified in 10% formic 
acid. The material was immersed in paraffin and subjected to histological processing in paraffin. The sections were stained 
with Masson’s trichrome and immunohistochemistry was carried out for the pro-apoptotic protein BCL-2. The images for the 
morphological and morphometric study were analyzed with the imaging program AxioVision 4.8 (Carl-Zeiss®, Germany). 
RESULTS: The combination of hyperprolactinemia and the ovariectomy procedure decreased the number of resting chondrocytes 
1.5-fold, the number of proliferative chondrocytes 1.8-fold; the percentage of resting cartilage 2.4-fold and the percentage 
of trabecular bone 2.1-fold, compared with respective control animals. CONCLUSION: The procedure of ovariectomy 
combined with the metoclopramide-induced hyperprolactinemia in female mice has showed marked bone degeneration 
due to significant decrease of cell proliferation in the epiphyseal growth plate and bone formation.
Resumo
OBJETIVO: Avaliar os efeitos do procedimento de ooforectomia e da hiperprolactinemia no disco epifisário da tíbia 
de camundongos fêmeas. MÉTODOS: Neste estudo, o disco epifisário de camundongos fêmeas ovariectomizadas 
(OVX) e/ou com hiperprolactinemia induzida por tratamento com 200 μg de metoclopramida por 50 dias (M) foi 
avaliado morfologicamente, morfometricamente e imunohistoquimicamente. Quarenta camundongos fêmeas e adultas 
foram divididas em quatro grupos, segundo o tratamento: Grupo V — animais tratados com solução salina; Grupo H 
— animais hiperprolactinêmicos; Grupo Ovx/V — animais ooforectomizados e tratados com o solução salina; 
Grupo Ovx/H — animais ooforectomizados e hiperprolactinêmicos. Após o período de tratamento, os animais foram 
sacrificados, as tíbias removidas e fixadas em formalina tamponada a 10% e descalcificadas em ácido fórmico a 
10%. O material foi emblocado em parafina e submetido a processamento histológico em parafina. Os cortes foram 
corados pelo tricrômico de Masson e foi feita a imunohistoquímica para a proteína pró-apoptótica BCL-2. As imagens 
para o estudo morfológico e morfométrico foram analisadas com o programa de imagem AxioVision 4.8 (Carl-Zeiss®, 
Alemanha). RESULTADOS: A combinação da hiperprolactinemia e do procedimento de ovariectomia levou à redução 
do número de condrócitos de repouso em 1,5 vezes; o número de condrócitos proliferativos em 1,8; a percentagem 
de cartilagem de repouso em 2,4, e a percentagem de osso trabecular em 2,1 vezes, em comparação com os 
respectivos animais controles. CONCLUSÃO: O procedimento de ooforectomia combinado com a condição de 
hiperprolactinemia induzida pela metoclopramida em camundongos fêmeas evidenciou degeneração óssea acentuada, 
devido à diminuição significativa da proliferação celular no disco epifisário e da formação óssea.
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Introduction
The bone formation through endochondral ossification 
is a process initiated by mesenchymal cell condensation, 
and it leads to the formation of a cartilaginous scaffold that 
will later be replaced by bone1. The outcome of this process 
is chondrocyte differentiation that leads to proliferation, 
hypertrophy, and concomitant expression of specific genes 
of cartilaginous tissue2. The terminal cartilage chondrocyte 
differentiation induces mineralization of cartilaginous 
extracellular matrix (ECM) and chondrocyte death by 
means of programmed cell death (PCD)3. However, in 
diarthroid joints, the cartilage scaffold is not fully replaced 
by bone. Two regions in these joints remain cartilaginous: 
the one that will be replaced (the growth plate) and the 
other that will never be replaced (articular cartilage)4. 
The growth plate is an epiphyseal hyaline cartilage located 
between the epiphysis and diaphysis of long bones, and 
it is responsible for the growth of these bones through an 
endochondral ossification process. This cartilage is divided 
into five distinct zones: resting, proliferative, hypertrophic, 
calcified, and ossified1,2. 
In the resting cartilage, the mesenchymal cells are 
flattened, isolated or paired with another cell, arranged 
irregularly in the matrix, and differentiated into pro-
liferative chondrocytes3. In the proliferative cartilage, 
the chondrocytes that are already differentiated become 
flattened and are arranged within gaps in a longitudinal 
direction and have a typical columnar orientation. The cells 
in this cartilage zone are able to proliferate; this is one of 
the factors leading to longitudinal bone growth4. In the 
hypertrophic cartilage, the chondrocytes are still arranged 
within the gaps in longitudinal columns, but these col-
umns are less organized than those in the proliferative 
cartilage zone. These chondrocytes are large in size as a 
result of the PCD process. The process of cartilage matrix 
mineralization begins by the release of intracellular cal-
cium in vesicles2,4. In the calcified cartilage, the cavities 
created by chondrocytes after apoptosis are invaded by 
blood capillaries and undifferentiated mesenchymal cells 
migrating from the adjacent connective tissue (perichon-
drium). These cells differentiate into osteoblasts to initiate 
bone matrix synthesis. Subsequently, the chondrocytes 
trapped in the mineralized matrix undergo apoptosis, and 
then cavities separated by thin strands of cartilage matrix 
begin to appear. Following this event, the formation of 
the bone marrow channel occurs via bone resorption 
activity of osteoclasts, which are responsible for resorp-
tion and remodeling of the bone1,5. In the ossification 
zone, myeloid tissue and blood vessels invade the spaces 
created by the chondrocytes, and osteoblasts originating 
from the undifferentiated cells produce bone matrix on 
the residual cartilage matrix, giving rise to gaps and 
channels. Thereafter, the osteoblasts become osteocytes, 
because they are entrapped in the bone matrix, and pri-
mary bone formation with complete calcification of the 
cartilaginous matrix is achieved6.
The processes of cellular proliferation and bone forma-
tion are influenced by several growth factors — epidermal 
growth factor (EGF) and platelet-derived growth factor 
(PDGF), sex steroids (estrogen, progesterone, and tes-
tosterone), and hormones (parathyroid hormone, growth 
hormone, and prolactin)7,8. 
Prolactin and its receptor are related to cell dif-
ferentiation and proliferation as well as bone mineral-
ization. Besides breast enlargement and stimulation of 
milk production by the mammary glands, prolactin also 
influences bone formation by calcium demand. Its action 
on cartilage and bone has been suggested because of the 
presence of prolactin receptors (PRL-R) in these tissues9. 
Metoclopramide has been used in treatments for 50 days 
to elicit experimental hyperprolactinemia (high levels of 
prolactin). There is evidence that hyperprolactinemia leads 
to hypogonadism with a consequent decrease in the levels 
of sex steroids, leading to the degeneration of cartilage 
and bone tissue in mice and humans10,11. 
Bilateral ovariectomy (OVX) is also used to induce 
hypogonadism and causes the degeneration of cartilage and 
bone in mice. However, the effects of hyperprolactinemia 
and OVX alone or in combination on cartilage and bone 
tissue are not well understood10. Therefore, the present 
study extends previous research in our laboratory12 by 
investigating the effects of hyperprolactinemia and OVX 
on the epiphyseal cartilage of the growth plate and bone 
formation in female mice. 
Methods
Forty adult female mice (Mus musculus), with ca. 
100 days and 35 g birth weight, from facilities of Cedeme – 
Federal University of São Paulo (UNIFESP) Center for 
Development of Experimental Models, were employed. 
The animals were housed in plastic cages with metal bars 
and artificial lighting, with a photoperiod of 12 hours 
light/12 hours dark. They were fed with standard chow 
(Labina-Purina®, Paulínia, Brazil) and water ad libitum; 
the average environment temperature was 22°C. 
All experimental protocols were approved by the 
Research Ethics Committee on Animal Experimentation 
of UNIFESP-EPM/project 1148/09 and the animals 
were maintained in accordance with the National 
Institutes of Health guidelines for the Care and Use 
of Laboratory Animals13.
The vaginal smear of the animals was collected daily 
for a week for monitoring the regularity of the estrous 
cycle and the characterization of the estrous cycle phases by 
361Rev Bras Ginecol Obstet. 2014; 36(8):359-66
Effects of hyperprolactinemia and ovariectomy on the tibial epiphyseal growth plate and bone formation in mice
Harris-Shorr staining cytological analysis14. Once observa-
tion of regular cycling as an indication of normal gonad 
activity was provided, the mice were randomly divided 
into 4 groups (n=10 animals for each group) and treated 
daily during 50 consecutive days, unless otherwise state, as 
follows: Vehicle (V): naïve controls, injected subcutaneously 
with 0.2 mL of the vehicle (saline solution – NaCl 0.9%); 
Metoclopramide rendered hyperprolactinemic (H): mice 
injected subcutaneously with 200 μg of metoclopramide 
(M) (Sigma®, St. Louis, United States) dissolved in 0.2 mL 
of the vehicle; Ovariectomized Vehicle (Ovx/V): Ovx 
mice treated subcutaneously with 0.2 mL of the vehicle; 
ovariectomized metoclopramide-hyperprolactinemic 
(Ovx/H): Ovx mice treated subcutaneously with 200 μg 
of M dissolved in 0.2 mL of the vehicle.
After being anesthetized with 16 mg/kg of xylazine 
(Anasedan® – Vetbrands Int, Florida, United States) and 
16 mg/kg of ketamine (Dopalen® – Vetbrands Int, Florida, 
United States) subcutaneously, the animals were positioned 
ventrally, and an about 1.5cm length skin incision was 
made bilaterally. The ovaries, uterine horn tip and the 
ovarian adjacent fat were exteriorized and then ovaries 
and surrounding fat were sectioned. Stitches were made 
with a 3.0 silk thread (Ethicon® – Johnson & Johnson, 
New Jersey, United States). After the procedure, the 
animals were placed in individual cages and 10 mg/kg of 
an association of dipyrone, adifenine hydrochloride and 
promethazine hydrocloride (Lisador® – Farmasa, United 
States) were administered in drinking water. After a 7-day 
recovery period, vaginal smears were taken daily during 
21 days to verify vaginal atrophy as indicative of female 
sex hormones depletion.
After 50 days of treatment, as already described, 
the mice were sacrificed by deep anesthesia (xylazine 
20 mg/kg plus ketamine 100 mg/kg, Vetbrands Int, 
Florida, United States), subcutaneously. The ani-
mals were positioned dorsally and tibiae were taken. 
The bones were fixed in formaldehyde (10%) in phosphate 
buffer during 24 hours and decalcified in 10% formic 
acid. After that, they were dehydrated in increasing 
concentrations of alcohol, diaphanized in xylene and 
embedded in paraffin. Inclusion of longitudinal sections 
was performed and 5 µm thick slides were prepared 
for further analyses15.
The slides with the sections were immersed in xylene, 
then in absolute ethanol, and then in Harris haematoxylin 
for 5 minutes, in solution A (fuchsin acid, acetic acid and 
distilled water) for 5 minutes, in solution B (fosfomolib-
dic acid and distilled water) for 5 minutes, and finally in 
solution C (aniline blue, acetic acid and distilled water). 
After that, they were immersed 3 times in acetic acid 
1%, and finally in ethanol, in xylene and mounted with 
coverslips and Ettelan® (Merck Chemicals, Germany)16.
Photomicrographs were taken from regions of the tibia 
in the proximal region of each slide using a field representa-
tive for each area and analyzed using a computerized system 
consisting of a light microscope (Carl Zeiss®, Germany), fitted 
to a high resolution camera – Axio Cam MRC (Carl Zeiss®, 
Germany) and a color video monitor (Samsung®, Korea). 
The images were obtained using the image analysis program 
AxioVision 4.8 (Carl Zeiss®, Germany). The morphological 
and morphometrical evaluation of the slides included: five 
regions of the epiphyseal growth plate at 400X objective, 
to obtain measures (μ) of total thickness and of each zone 
of cartilage (resting, proliferative and hypertrophic); five 
regions of the epiphyseal growth plate at 400X objective, 
to obtain the counting of chondrocytes in each zone of 
cartilage (resting, proliferative and hypertrophic) and four 
regions of the epiphyseal growth plate at 100X objective, 
using a Weibel’s reticle of 36 points, which was superim-
posed on each image, to obtain the percentage of remaining 
cartilage, trabecular bone and bone marrow, determining 
the percentage of bone formation17.
The results (mean ± standard deviation) were analyzed 
by ANOVA followed by Tukey’s post hoc test with the 
computer program Prizma® (California, United States)18. 
Differences at p≤0.05 were taken as significant.
For immunohistochemistry analysis of the pro-
apoptotic protein – BCL-2 antibody, sections were 
initially submitted to deparaffinization in xylene and 
alcohol series for 5 minutes, with subsequent recovery 
of antigenic sites on steam fluent (pot value) for 30 min-
utes. The slides were washed twice for 5 minutes in a 
shaker with 0.1 M phosphate buffered saline (PBS), 
pH 7.5 and then blocking endogenous peroxidase was 
carried out by immersion in hydrogen peroxide at 1% 
for 30 minutes, at room temperature. Then, the slides 
were washed again in PBS (2x 5 min) and blocking of 
nonspecific sites was performed with normal goat serum 
diluted in 0.2 M PBS, pH 7.4.
After incubation overnight at 4°C in a dark chamber 
with primary antibodies monoclonal anti-BCL-2 anti-
body (IMUNY™, Rheabiotech Ltda., Brazil) diluted 
1:400 in PBS, the samples were subjected to repeated 
washses in PBS, and then incubated for 30 minutes at 
room temperature with secondary antibody anti-mouse 
IgG conjugated with biotin (LSAB 2 Kit, Dako) at a 
dilution of 1:400.
The samples were subsequently incubated with AB 
reagent (streptavidin-biotin complex, LSAB 2, DAKO) for 
30 minutes at room temperature, and developed with DAB 
(Sigma ChemicalCo, St. Louis, MO, United States) for 1 
minute at room temperature. The sections were then coun-
terstained with Harris hematoxylin solution for 20 seconds, 
fixed in alcohol series – xylene and mounted with cover slip 
and mounting medium Permount (Fisher, United States).
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Immunohistochemistry was performed at the Laboratory 
Rheabiotech/Imuny (Campinas, São Paulo, Brazil).
We adopted as negative control the absence of primary 
antibody and the appearance of brown cells and extra-
cellular matrix of the growth plate for positive pattern. 
The results of the evaluation of the expression of BCL-2 
antibody were qualitatively guaranteed by the presence 
of cell marking.
Results
Figure 1A shows the morphology of the mouse 
epiphyseal growth plate of the naïve control group (V). 
The chondrocytes of the epiphyseal growth plate carti-
lage are organized into morphologically distinct zones: 
resting, proliferative, and hypertrophic. The area of the 
resting cartilage is characterized by a layer of flattened 
chondrocytes with small spaces between the cells. The pro-
liferative cartilage is characterized by a large number of 
chondrocytes with small spaces between rows of flattened 
and arranged chondrocytes. Finally, the hypertrophic 
cartilage is characterized by small number of rounded 
and arranged chondrocytes. 
In the group treated with metoclopramide 
(H; Figure 1B), the resting and proliferative cartilages 
have fewer and less organized chondrocytes with more 
spaces between them, and the hypertrophic cartilage 
has a larger number of chondrocytes, which are much 
more rounded and less arranged, in comparison with the 
control group. 
Figure 1. Photomicrographs of the tibial epiphyseal growth plate of the groups (n=10). (A) vehicle (V); (B) hyperprolactinemic (H); (C) ovariectomized 
vehicle (Ovx/V); (D) ovariectomized hyperprolactinemic (Ovx/H), with a 40X objective. Stained with Masson’s trichrome.
20 μm 20 μm
20 μm
20 μm
A
C
B
D
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In the group subjected to bilateral OVX and treated 
with vehicle (Ovx/V; Figure 1C), the resting and prolif-
erative cartilages showed fewer disorganized flattened 
chondrocytes with larger spaces between them, and the 
hypertrophic cartilage showed a larger number of rounded 
and disorganized chondrocytes, in comparison with the 
control group. 
In the group subjected to OVX and metoclopramide-
hyperprolactinemia (Ovx/H; Figure 1D), the resting 
and proliferative cartilages showed few flattened, widely 
spaced, and disorganized chondrocytes in a small number 
of rows with large spaces between them, and the hyper-
trophic cartilage showed a great amount of rounded and 
disorganized chondrocytes, in comparison with the group 
treated only with metoclopramide-hyperprolactinemia (H). 
The morphometrical results obtained from the 
evaluation of the resting cartilage percentage (Table 1; 
p≤0.05) showed that this percentage in the control (V) 
group (a) was not significantly different from that in the 
H and Ovx/V groups, but it was different from that in 
the Ovx/H group. In the evaluation of the trabecular 
bone percentage (Table 1; p≤0.05), in the V group (a), 
this percentage was significantly different from that 
in the H, Ovx/V, and Ovx/H groups; in the H group (b), 
this percentage was significantly different from that in the 
Ovx/V and Ovx/H groups. In the evaluation of the bone 
marrow percentage (Table 1; p≤0.05), in the V group (a), 
this percentage was significantly different from that in 
the H, Ovx/V, and Ovx/H groups; in the Ovx/V group 
(b), this percentage was significantly different from that 
in the Ovx/H group. 
In the evaluation of the number of resting chon-
drocytes (Table 2; p≤0.05), the V group (a) had a larger 
number than the Ovx/V and Ovx/H groups; the H group 
(b) had a larger number than the Ovx/H group. Moreover, 
the Ovx/V group (c) also had a larger number than the 
Ovx/H group. In the evaluation of the number of pro-
liferative chondrocytes (Table 2; p≤0.05), the V group 
(a) had a larger number than the H, Ovx/V, and Ovx/H 
groups; the H group (b) had a larger number than the 
Ovx/V and Ovx/H groups; and the Ovx/V group (c) had 
a larger number than the Ovx/H group. In the evaluation 
of the number of hypertrophic chondrocytes (Table 2; 
p≤0.05), the numbers were not different between the V (a) 
and the H groups, but the V group had a smaller number 
than the Ovx/V and Ovx/H groups. In addition, the H 
group (b) had a smaller number than the Ovx/H group. 
In the evaluation of the resting cartilage zone thick-
ness (Table 3; p≤0.05), the V group (a) had a thicker zone 
than the H, Ovx/V, and Ovx/H groups; the Ovx/V group 
(b) had a thicker zone than the Ovx/H group. In the 
evaluation of the proliferative cartilage zone thickness 
(Table 3; p≤0.05), the V group (a) had a thicker zone than 
the H, Ovx/V, and Ovx/H groups; the H group (b) had 
a thicker zone than the Ovx/V and Ovx/H groups; and 
the Ovx/V group (c) had a thicker zone than the Ovx/H 
group. In the evaluation of the hypertrophic cartilage 
zone thickness (Table 3; p≤0.05), the V group (a) had a 
thicker zone than the H, Ovx/V, and Ovx/H groups; the 
H group (b) had a thicker zone than the Ovx/H group. 
In the evaluation of total cartilage thickness (Table 3; 
p≤0.05), the V group (a) had a thicker cartilage than the 
H, Ovx/V, and Ovx/H groups, and the Ovx/V group (b) 
had a thicker cartilage than the Ovx/H group. 
The immunohistochemistry results (Figures 2A to 2D) 
showed only positive staining for early hypertrophic 
Table 2. Analysis of the chondrocytes number (p≤0.05) of the growth plate cartilage 
zones of the groups 
 Analysis of the chondrocytes number
V H Ovx/V Ovx/H
Resting chondrocytes 11.2 a 10.2 b 9.1 c 7.1
Proliferative chondrocytes 46.2 a 38.8 b 30.1 c 26.2
Hypertrophic chondrocytes 28.0 a 29.6 b 31.6 33.6
V: vehicle; H: hyperprolactinemic; Ovx/V: ovariectomized vehicle; Ovx/H: 
ovariectomized hyperprolactinemic.
Groups: (A) resting (a - comparison with Ovx/V and Ovx/H; b - comparison 
with Ovx/H); (B) proliferative (a - comparison with H, Ovx/V and Ovx/H; b - 
comparison with Ovx/V and Ovx/H; c - comparison with Ovx/H); (C) hypertrophic 
(a - comparison with Ovx/V and Ovx/H; b - comparison with Ovx/H).
Table 1. Analysis of the bone formation percentage (p≤0.05) of the groups 
 
 Bone formation percentage
V H Ovx/V Ovx/H
Resting cartilage 3.7 a 3.1 2.8 1.6
Trabecular bone 9.3 a 7.2 b 5.4 4.3
Bone marrow 21.1 a 27.7 b 25.6 30.0
V: vehicle; H: hyperprolactinemic; Ovx/V: ovariectomized vehicle; Ovx/H: 
ovariectomized hyperprolactinemic. 
Groups: (A) resting cartilage (a - comparison with Ovx/H); (B) trabecular bone 
(a - comparison with H, Ovx/V and Ovx/H; b - comparison with Ovx/V and 
Ovx/H); (C) bone marrow (a - comparison with H, Ovx/V and Ovx/H; b - 
comparison with Ovx/H).
Table 3.  Analysis of the thickness (μm; p≤0.05) of the growth plate cartilage zones 
of the groups 
 
 
 Analysis of the cartilage zones thickness 
V H Ovx/V Ovx/H
Resting thickness 32.5 a 26.7 28.1 b 25.4
Proliferative thickness 52.0a 41.2 b 33.9 c 30.8
Hypertrophic thickness 26.3 a 29.1 b 30.9 32.7
Total thickness 111.0 a 97.1 93.0 b 89.0
V: vehicle; H: hyperprolactinemic; Ovx/V: ovariectomized vehicle; Ovx/H: 
ovariectomized hyperprolactinemic.
Groups: (A) resting (a - comparison with H, Ovx/V and Ovx/H; b - comparison 
with Ovx/H); (B) proliferative (a - comparison with H, Ovx/V and Ovx/H; b - 
comparison with Ovx/V and Ovx/H; c - comparison with Ovx/H); (C) hipertrophic 
(a - comparison with H, Ovx/V and Ovx/H; b - comparison with Ovx/H); (D) 
total (a - comparison with H, Ovx/V and Ovx/H; b - comparison with Ovx/H).
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chondrocytes and mature chondrocytes, and no proliferative 
chondrocytes were observed. This is because of the aging 
of the animals (Figure 2A), bilateral OVX (Figure 2B), 
and hyperprolactinemia (Figures 2C and 2D).
Discussion
The growth plate is responsible for the growth of long 
bones via the process of endochondral ossification, and it 
goes through a series of events called “bone turnover”6. 
These events lead to the formation of a cartilaginous scaffold 
that will be replaced by bone1. The outcome of this process 
is chondrocyte differentiation leading to proliferation and 
hypertrophy that induces the mineralization of cartilaginous 
ECM and chondrocyte death by means of PCD2,3.
Complex relationships exist between systemic factors 
and the paracrine, autocrine, and intrinsic influences that 
act together with the sex steroids to maintain cartilage 
homeostasis7,19. Thus, disturbances in this network can 
lead to damage in the cartilage and result in inadequate 
bone formation3. Our data show that disturbances in 
this network occurred in mice following ovariectomy 
and hyperprolactinemia. The animals treated with the 
vehicle developed the best quality of the growth plate 
cartilage and bone. The ovariectomized animals devel-
oped poor quality cartilage and bone compared with 
the V group; after treatment with metoclopramide, the 
hyperprolactinemic animals developed poorer quality 
cartilage and bone than the other two groups. In fact, 
after treatment with metoclopramide, the ovariectomized 
Figure 2.  Photomicrographs of the tibial epiphyseal growth plate evidencing positive marking (arrows) for immunohistochemistry analysis of the pro-
apoptotic protein - BCL-2 antibody. (A) vehicle (V); (B) hyperprolactinemic (H); (C) ovariectomized vehicle (Ovx/V); (D) ovariectomized hyperprol-
actinemic (Ovx/H), with a 100X objective.
A
C
B
D
365Rev Bras Ginecol Obstet. 2014; 36(8):359-66
Effects of hyperprolactinemia and ovariectomy on the tibial epiphyseal growth plate and bone formation in mice
and hyperprolactinemic animals developed the poorest 
quality cartilage and bone compared with all the groups. 
This outcome can potentially have a negative impact on 
locomotor system functioning20. 
Upon bilateral OVX, the production of sex steroids, 
such as estrogen and testosterone, ceases12. These steroids 
as well as progesterone are very important in the main-
tenance of cellular proliferation and bone formation21. 
If they are produced in lesser quantities in the body, the 
cartilage is greatly damaged and bone formation reduces, 
leading to very poor quality cartilage and bone21-24.
The combination of OVX and hyperprolactinemia 
resulted in the lowest number of mesenchymal cells present 
in the resting cartilage zone, which is vital to counteract 
cartilage damage20
.
 This explains why this combined treat-
ment results in the greatest cartilage degeneration and 
decreased bone formation, as observed in our experiments12. 
Prolactin acts in cartilage and bone through its local 
PRL-R. The transcription of these receptors is observed only 
in osteoblasts and not in osteoclasts. This fact suggests that 
prolactin is involved in bone formation and the mainte-
nance of bone density by regulating calcium levels in conditions 
of increased demand, e.g., during gestation and lactation, 
and in an event of bone mass loss (osteoporosis)10,19,22,23,25. 
Prolactin secretion is maintained under hypothalamic 
inhibitory control mediated by the release of dopamine 
and the much more effective gamma-aminobutyric acid26. 
Plasma concentrations of prolactin can vary and some-
times increase because of physiological, pathological, and 
pharmacological issues27,28. Hyperprolactinemic states 
are related to decreased secretions of estrogen, proges-
terone, and testosterone (i.e., a hypogonadism-like state) 
followed by a decreased bone formation10,29. As shown 
by the results reported in this study, metoclopramide-
induced hyperprolactinemia12 negatively affects the 
quality of cartilage.
A drastic reduction in sex steroid production resulting 
from the combination of OVX and hyperprolactinemia 
and the resulting hypogonadism diminished cellular 
proliferation of cells in the growth plate epiphyseal car-
tilage as well as diminished bone formation in the tibia, 
resulting in the strongest negative effect on bone quality.
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